Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
Neuro-Oncology Practice|June 3, 2015
Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experienceGrant M Clark, Andrew M McDonald, Louis B Nabors, et al.
Advances in Radiation Oncology|March 5, 2021
Control and Toxicity in Melanoma Versus Other Brain Metastases in Response to Combined Radiosurgery and PD-(L)1 Immune Checkpoint InhibitionRoman L Travis, Samuel R Marcrom, Matthew H Brown, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2024
Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastomaColin H Quinn, Janet R Julson, Hooper R Markert, et al.
Neurosurgery|May 30, 2014
Comparison of plan quality and delivery time between volumetric arc therapy (RapidArc) and Gamma Knife radiosurgery for multiple cranial metastasesEvan M Thomas, Richard A Popple, Xingen Wu, et al.
Translational Oncology|October 19, 2016
Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of RhabdomyosarcomaAlicia M Waters, Laura L Stafman, Evan F Garner, et al.
Practical Radiation Oncology|February 26, 2021
Transition From Manual to Automated Planning and Delivery of Volumetric Modulated Arc Therapy Stereotactic Radiosurgery: Clinical, Dosimetric, and Quality Assurance ResultsRichard A Popple, Matthew H Brown, Evan M Thomas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2019
Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical modelsBenjamin B Kasten, Ke Jiang, Denzel Cole, et al.
Neuro-Oncology|July 19, 2015
Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex virusesGregory K Friedman, Blake P Moore, Li Nan, et al.
Theranostics|August 15, 2019
Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-OncologyBenjamin B Kasten, Neha Udayakumar, Jianmei W Leavenworth, et al.
Advances in Radiation Oncology|July 26, 2017
A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastasesJohn B Fiveash, Waleed O Arafat, George E Naoum, et al.
Pageof 14